June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
The dark atrophy: an angio-OCT study
Author Affiliations & Notes
  • Alessandra Acquistapace
    Sacco Hospital Eye Clinic, Department of Clinical Science, San Fermo della Battaglia, Italy
  • Marco Pellegrini
    Sacco Hospital Eye Clinic, Department of Clinical Science, San Fermo della Battaglia, Italy
  • Marta Oldani
    Sacco Hospital Eye Clinic, Department of Clinical Science, San Fermo della Battaglia, Italy
  • Matteo Giuseppe Cereda
    Sacco Hospital Eye Clinic, Department of Clinical Science, San Fermo della Battaglia, Italy
  • Andrea Giani
    Sacco Hospital Eye Clinic, Department of Clinical Science, San Fermo della Battaglia, Italy
  • Vittoria Ravera
    Sacco Hospital Eye Clinic, Department of Clinical Science, San Fermo della Battaglia, Italy
  • Giovanni Staurenghi
    Sacco Hospital Eye Clinic, Department of Clinical Science, San Fermo della Battaglia, Italy
  • Footnotes
    Commercial Relationships Alessandra Acquistapace, None; Marco Pellegrini, Bayer (S); Marta Oldani, None; Matteo Cereda, None; Andrea Giani, Novartis Advisory Board (C); Vittoria Ravera, None; Giovanni Staurenghi, Alcon Laboratories, Inc (C), Allergan, Inc (C), Bayer (C), Boehringer (C), Genentech (C), GlaxoSmithKline (C), Heidelberg Engineering (C), Novartis Pharmaceuticals corporation (C), Novartis Pharmaceuticals corporation (S), Optos, Inc (C), Optos, Inc (C), Optovue (S), Roche (C), Zeiss (C), Zeiss (S)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3353. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alessandra Acquistapace, Marco Pellegrini, Marta Oldani, Matteo Giuseppe Cereda, Andrea Giani, Vittoria Ravera, Giovanni Staurenghi; The dark atrophy: an angio-OCT study. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3353.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: to evaluate the status of choriocapillaris and choroidal structures using angio-OCT in patients affected by macular atrophy secondary to age-related macular degeneration (GA) and Stargardt disease (STGDT).

Methods: Retrospective study. All the patients underwent a complete ophthalmological examination including blue and green autofluorescence (B-FAF, G-FAF), fluorescein (FA) and indocyanine green (ICGA) angiography, enhanced depth imaging spectral domain optical coherence tomography (SD-EDI OCT) (HRA+OCT Spectralis, Heidelberg Engineering, Heidelberg, Germany) and angio-OCT using AngloVue technologies (Optovue, in).

Results: 20 eyes of 10 patients affected by GA and 20 eyes of 10 patients affected by STGDT were included in the study. Mean age was 53,3 for STGDT patients and 76,88 for GA. Atrophy was hypofluorescent in both B-FAF and G-FAF in all the cases. In the early frames FA displayed hyperfluorescence in the atrophic area in 80% of GA and 0% of STGDT patients whereas dark choroid was present in 0% of patients and 90% respectively. ICGA showed, in late frames, hypocyanescence in 95% of STGTD and 16% of GA patients and isocyanescence in 84% of GA patients. At Angio-OCT imaging it was possible to detect a global rarefaction of choroidal layers in 94% of GA patients with no selective loss of choriocapillaris while in STGDT patients loss of choriocapillaris was typically antecedent to the loss of the other layers.

Conclusions: SSADA analysis in STGDT patients displayed a selective involvement of choriocapillaris compared to GA population. This finding results in agreement with possible expression of ABCA4 at this level and with previous ICGA studies.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×